Prognosis
Pfizer to Supply U.S. With Millions of Shots for Young Kids
- U.S. retains option for updated vaccine tailored to variants
- Doses could be used for rollout of boosters or shots for kids
Photographer: Emily Elconin/Bloomberg
This article is for subscribers only.
Pfizer Inc. and BioNTech SE will supply the U.S. with another 200 million doses of their Covid-19 shot, setting up a stream of vaccine deliveries through next April in a push to protect kids and potentially provide boosters.
The White House is setting its sights on immunizing children under the age of 12, who aren’t yet eligible, and potentially deploying booster doses if new data shows their necessity.